Meloxicam
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00814 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 21 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | acromesomelic dysplasia, Hunter-Thompson type | KG + DL |
| 2 | brachyolmia-amelogenesis imperfecta syndrome | KG + DL |
| 3 | myosclerosis | KG + DL |
| 4 | brachyolmia | KG + DL |
| 5 | pseudoachondroplasia | KG + DL |
| 6 | spondyloarthropathy, susceptibility to | KG + DL |
| 7 | rheumatoid nodulosis | KG + DL |
| 8 | rheumatoid factor-positive polyarticular juvenile idiopathic arthritis | KG + DL |
| 9 | WHIM syndrome | KG + DL |
| 10 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 11 | brachydactyly-syndactyly syndrome | KG + DL |
| 12 | juvenile chronic polyarthritis | KG + DL |
| 13 | ankylosing spondylitis | KG + DL |
| 14 | vertebral disease | KG + DL |
| 15 | rheumatoid vasculitis | KG + DL |
| 16 | combined immunodeficiency due to moesin deficiency | KG + DL |
| 17 | hypermobility of coccyx | KG + DL |
| 18 | inflammatory spondylopathy | KG + DL |
| 19 | Kummell disease | KG + DL |
| 20 | polyarticular juvenile rheumatoid arthritis | KG + DL |
| 21 | leukoplakia | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.